AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
167 hedge funds and large institutions have $1.43B invested in Aerie Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 39 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
37% less capital invested
Capital invested by funds: $2.26B → $1.43B (-$826M)
Holders
167
Holding in Top 10
7
Calls
$15.8M
Puts
$11.8M
Top Buyers
| 1 | +$42.1M | |
| 2 | +$11.5M | |
| 3 | +$9.81M | |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$9.46M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$7.53M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$16.1M | |
| 3 | -$16M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$13.3M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$7.79M |